Research Integrity Policy

Responsible Office: Office of the Vice Chancellor for ResearchPolicy Steward: Office of Research Integrity and EthicsPolicy contact: ORIE@wustl.edu Created 10/18/2000Revised 01/01/2026 Appendix 1 – Organizational Structure DetailsAppendix 2 – Documentation and Communication Requirements  I. Purpose  This policy provides a framework to resolve allegations of research misconduct as rapidly and fairly as possible and to protect […]

Procedures for the Use of Controlled Substances in Laboratory and Animal Research​​​

Created 07/2010Revised 06/ 2016; Administrative update 6/2025 I – Requirements for AcquisitionII – Institutional Animal Care and Use Committee (IACUC) ProtocolsIII – Background ChecksIV – DAF and DCM Stockroom ProceduresV – Controlled Substances InventoriesVI – Drug Storage, Records of Use & SecurityVII – DisposalVIII – AuditsIX – SanctionsX – Recordkeeping Requirements APPENDICES A – H […]

Policy for the Use of Controlled Substances in Laboratory and Animal Research

Created 07/08/2010Revised 03/2016 IntroductionScopeApplicable RegulationsResponsibilitiesSanctionsApproval Introduction and Purpose Certain drugs and chemical precursors fall under the jurisdiction of the Missouri Bureau of Narcotics and Dangerous Drugs (BNDD) and the US Department of Justice (DOJ) Drug Enforcement Administration (DEA). These drugs and chemicals are known as Controlled Substances and must be purchased, maintained, used and disposed […]

Noncompliance Assessment Process and Potential Sanctions

Originally effective: August 1998Revised: September 28, 2023 1. Assessment When a potential failure to comply with WU’s policies and processes governing research conflicts of interests is identified, the CIRC Chair will conduct an assessment of the situation and make a determination as to whether the individual failed to comply and the extent of the non-compliance. […]